Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.08K Buy
43
+19
+79% +$2.19K ﹤0.01% 878
2026
Q1
$2.87K Buy
+24
New +$3.15K ﹤0.01% 864
2024
Q4
Sell
-2
Closed -$271 812
2024
Q3
$271 Sell
2
-1,198
-100% -$160K ﹤0.01% 684
2024
Q2
$163K Hold
1,200
0.02% 198
2024
Q1
$155K Buy
+1,200
New +$145K 0.02% 204
2023
Q4
Sell
-7
Closed -$638 711
2023
Q3
$638 Hold
7
﹤0.01% 379
2023
Q2
$789 Sell
7
-85
-92% -$8.99K ﹤0.01% 599
2023
Q1
$9.63K Hold
92
﹤0.01% 553
2022
Q4
$10.2K Sell
92
-12
-12% -$1.26K ﹤0.01% 549
2022
Q3
$9K Buy
104
+36
+53% +$3.27K ﹤0.01% 705
2022
Q2
$5K Buy
+68
New +$5.62K ﹤0.01% 781

Other funds holding XYL

Crewe Advisors's XYL Position: Q2 2026 in Review

Crewe Advisors increased its Xylem (XYL) stake by 79% in Q2 2026, buying an estimated $2.19K and bringing the position to 43 shares worth $5.08K. The position accounts for ﹤0.01% of the portfolio, ranked #878.

Crewe Advisors first reported a position in XYL in Q2 2022 and has held it in 11 quarters since. The position peaked at $163K in Q2 2024. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Crewe Advisors held 43 shares of Xylem worth $5.08K as of Q2 2026.
  • Crewe Advisors bought 19 Xylem shares in Q2 2026, an estimated $2.19K.
  • Xylem made up ﹤0.01% of Crewe Advisors's portfolio in Q2 2026, its #878 holding.
  • Crewe Advisors first reported a position in Xylem in Q2 2022 and has held it in 11 quarters since.
  • Crewe Advisors's Xylem position peaked at $163K in Q2 2024.
  • 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Crewe Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.